Sponsor or institution

Clinical trials and research at Mercator Medsystems, INC.

• 2Clinical trials
• 3NIH research projects
• 3Countries

All recruiting trials (2)

• Using dexamethasone to reduce inflammation after blood clot removal in the leg

  This study is testing if giving dexamethasone directly around the veins after removing a blood clot can help reduce inflammation and improve symptoms for people with deep vein thrombosis.

  Recruiting at 18 sites Phase 2 Mercator MedSystems, Inc. · Scottsdale, Arizona and 21 other locations · NCT04862468

• Temsirolimus injected around below-knee arteries to improve angioplasty or atherectomy results

  This trial will test whether injecting low-dose temsirolimus around below-knee arteries at the time of angioplasty or atherectomy reduces amputations and the need for repeat procedures in people with symptomatic peripheral artery disease or critical limb ischemia.

  Recruiting at 2 sites Phase 3 Mercator MedSystems, Inc. · Houma, Louisiana and 1 other locations · NCT04433572

NIH-funded research (3)

Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.

• Improved Sirolimus-Analog Adventitial Delivery for Below-the-Knee PAD

  A new sirolimus-like drug delivery method targeting the artery outer layer aims to improve blood flow and limb outcomes for people with below-the-knee peripheral artery disease.

  NIH research Mercator Medsystems, INC. · San Leandro, UNITED STATES · NIH-11299471

• Stopping long-term leg damage after deep vein clots by giving anti-inflammatory medicine around the vein

  This will try giving anti-inflammatory medicine around the affected vein to lower the chance of long-term swelling, pain, and skin problems after a deep vein clot (DVT).

  NIH research Mercator Medsystems, INC. · San Leandro, UNITED STATES · NIH-11194237

• Reducing chronic leg problems after blood clots

  This study is looking at a new way to help people who have had a blood clot (DVT) avoid developing a painful condition called post-thrombotic syndrome (PTS) by using special treatments that reduce inflammation in the affected blood vessels, so you can feel better and improve your quality of life.

  NIH research Mercator Medsystems, INC. · San Leandro, UNITED STATES · NIH-10823041

Quick answers

How many clinical trials run by Mercator Medsystems, INC. are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 3 countries. The most sites are in United States (2 trials), Ireland (1 trial), United Kingdom (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 3: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →